The Division of Gastroenterology and Hepatology offers a world-class team of medical, surgical, and pediatric liver disease specialists offering cutting-edge therapies in the treatment of advanced liver disease and liver transplantation. We strive to optimize the quality of life of our patients by providing comprehensive multidisciplinary care from the moment of referral. Our team provides a complete range of innovative diagnostic and treatment services:
Fatty Liver Disease
Our physicians are leaders in the clinical care of patients with fatty liver disease, including nonalcoholic steatohepatitis (NASH). In addition, studies headed up by Drs. Argo, Al-Osiami, and Caldwell are investigating newer diagnostic tests and therapies of this potentially progressive form of liver disease.
Viral Hepatitis (Hepatitis C and Hepatitis B)
Specialists in both the Hepatology Group and the Infectious Disease group have partnered to offer a variety of new therapies tailored to the individual patient. Strong nursing support and the availability of advanced research studies with new combinations enhance the viral hepatitis program.
Liver Cancer and Liver Lesions
A multidisciplinary team provides a very strong clinical foundation to offer all forms of therapy from surgical to radiological to medicinal. Clinical trials are also underway to explore newer potential options. Focused Hepatology clinics under Drs. Northup and Caldwell often provide the starting point for patients undergoing evaluation and treatment for this condition.
Coagulation in Liver Disease
The UVA Hepatology group has developed a strong presence in this aspect of hepatology. Under the direction of Dr. Stephen Caldwell, Director of Hepatology, a number of clinical research efforts are underway in this field. These are headed up by Drs. Patrick Northup, Neeral Shah, and Nick Intagliata, and include a University-based and international collaborative team. In addition, the 5th International Symposium on Coagulation in Liver Disease has been co-organized with University Hospital of Padua and is set for September 2013 -- http://www.coagulationinliverdisease.org/.
Living Donor Transplantation
UVA is one of a small number sites in the U.S. to offer this novel and life-saving form of liver transplantion. Our transplant team includes hepatologists, surgeons, pathologists, radiologists, nephrologists, pulmonologists and specialty nurse coordinators. Patients are managed by a multidisciplinary team headed up by Dr. Al-Osaimi, the Medical Director of Liver Transplantation, Dr. Dan Maluf, the Surgical Director of the Living Donor Program, and Dr. Shawn Pelletier, the Surgical Director of Liver Transplantation.
Innovative Use of Immunosuppressants
Instrumental in developing advanced protocols resulting in better patient outcomes in controlling the response to hepatitis.